Details for New Drug Application (NDA): 050126
✉ Email this page to a colleague
NDA 050126 describes BICILLIN, which is a drug marketed by Wyeth Ayerst and King Pharms Llc and is included in five NDAs. Additional details are available on the BICILLIN profile page.
The generic ingredient in BICILLIN is penicillin g benzathine; penicillin g procaine. There are ninety-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the penicillin g benzathine; penicillin g procaine profile page.
The generic ingredient in BICILLIN is penicillin g benzathine; penicillin g procaine. There are ninety-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the penicillin g benzathine; penicillin g procaine profile page.
Summary for 050126
| Tradename: | BICILLIN |
| Applicant: | Wyeth Ayerst |
| Ingredient: | penicillin g benzathine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050126
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 300,000 UNITS/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
